GGrantIndex
← Leaderboards

Richard L. Klemke

Scripps Research Institute

$17,531,405
Attributed
$17,676,164
Total exposure
26
Grants
22
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,676,164 · 26

By mechanism

R01$14,572,413 · 6
R41$1,110,918 · 3
P41$692,096 · 14
U54$516,199 · 1
R29$495,020 · 1
R43$289,518 · 1

Top collaborators

Most similar at Scripps Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsSignal TransductionBaseProteinsCell MotilityMediatingNeoplasm MetastasisCancer CellTissuesTechnologyIn VivoInvadedProteomicsExtracellular MatrixLaboratoriesAnimal ModelResolutionComplexTumor ProgressionMolecularStructureMalignant NeoplasmsBlood VesselsSignal Pathway

Grant awards (72)

Bioengineering of Enucleated Cell Therapeutics for Treating Inflammatory Diseases$550,213
R01 · FY2025 · EB · contact PI
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC$375,250
R01 · FY2024 · CA · contact PI
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC$387,100
R01 · FY2023 · CA · contact PI
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC$387,100
R01 · FY2022 · CA · contact PI
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC$394,896
R01 · FY2021 · CA · contact PI
Bioengineering a Novel Therapeutic Transporter that Crosses the Blood Brain Barrier to Treat Brain Disorders$324,986
R41 · FY2021 · TR · contact PI
Development of a Novel Therapeutic Transporter to Treat Metastatic Cancers$399,346
R41 · FY2020 · CA · contact PI
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC$393,750
R01 · FY2020 · CA · contact PI
Development of CA-IL-12 for Triple Negative Breast Cancer$386,586
R41 · FY2020 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$78,750
R01 · FY2019 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$376,399
R01 · FY2018 · CA · contact PI
Vascular communication in metastatic brain colonization$321,625
R01 · FY2018 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$376,399
R01 · FY2017 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$351,599
R01 · FY2017 · CA · contact PI
Vascular communication in metastatic brain colonization$321,625
R01 · FY2017 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$378,402
R01 · FY2016 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$351,599
R01 · FY2016 · CA · contact PI
Vascular communication in metastatic brain colonization$321,625
R01 · FY2016 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$378,402
R01 · FY2015 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$351,599
R01 · FY2015 · CA · contact PI
Vascular communication in metastatic brain colonization$321,625
R01 · FY2015 · CA · contact PI
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures$378,402
R01 · FY2014 · CA · contact PI
Vascular communication in metastatic brain colonization$321,625
R01 · FY2014 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$280,911
R01 · FY2014 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$289,599
R01 · FY2013 · CA · contact PI
Pre-clinical development of a novel pancreatic cancer chemotherapeutic$289,518
R43 · FY2013 · CA
Imagining Human Cancer Progression in a Novel Zebrafish Model$310,970
R01 · FY2012 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$288,664
R01 · FY2012 · CA · contact PI
Imagining Human Cancer Progression in a Novel Zebrafish Model$310,970
R01 · FY2011 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$288,667
R01 · FY2011 · CA · contact PI
Mechanisms of Lamellipodia Growth and Retraction$264,995
R01 · FY2011 · GM · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$28,669
P41 · FY2011 · RR · contact PI
Imagining Human Cancer Progression in a Novel Zebrafish Model$320,588
R01 · FY2010 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$297,592
R01 · FY2010 · CA · contact PI
Mechanisms of Lamellipodia Growth and Retraction$267,671
R01 · FY2010 · GM · contact PI
PROTEOMIC$115,850
U54 · FY2010 · GM · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$64,248
P41 · FY2010 · RR · contact PI
DYNAMIC PROTEOMICS OF TUMOR CELL MIGRATION AND THE LAMELLIPODIA PHOSPHOPROTEOME$32,124
P41 · FY2010 · RR · contact PI
Imagining Human Cancer Progression in a Novel Zebrafish Model$320,588
R01 · FY2009 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$291,759
R01 · FY2009 · CA · contact PI
Mechanisms of Lamellipodia Growth and Retraction$270,375
R01 · FY2009 · GM · contact PI
PROTEOMIC$111,753
U54 · FY2009 · GM · contact PI
DYNAMIC PROTEOMICS OF TUMOR CELL MIGRATION AND THE LAMELLIPODIA PHOSPHOPROTEOME$65,045
P41 · FY2009 · RR · contact PI
CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME$32,523
P41 · FY2009 · RR · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$32,523
P41 · FY2009 · RR · contact PI
Imagining Human Cancer Progression in a Novel Zebrafish Model$320,588
R01 · FY2008 · CA · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$283,260
R01 · FY2008 · CA · contact PI
Mechanisms of Lamellipodia Growth and Retraction$270,375
R01 · FY2008 · GM · contact PI
PROTEOMIC$114,909
U54 · FY2008 · GM · contact PI
CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME$72,037
P41 · FY2008 · RR · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$72,037
P41 · FY2008 · RR · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$272,197
R01 · FY2007 · CA · contact PI
PROTEOMIC$104,720
U54 · FY2007 · GM · contact PI
CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME$62,953
P41 · FY2007 · RR · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$41,969
P41 · FY2007 · RR · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$274,861
R01 · FY2006 · CA · contact PI
Mechanisms of Lamellipodia Growth & Retraction$264,022
R01 · FY2006 · GM · contact PI
PROTEOMIC$68,967
U54 · FY2006 · GM · contact PI
CHARACTERIZATION OF THE NEURITE PHOSPHOPROTEOME$63,044
P41 · FY2006 · RR · contact PI
CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME$63,044
P41 · FY2006 · RR · contact PI
Survival Mechanisms of Invasive Carcinoma Cells$334,106
R01 · FY2005 · CA
Mechanisms of Lamellipodia Growth &Retraction$200,123
R01 · FY2005 · GM
Mechanisms of Lamellipodia Growth &Retraction$106,385
R01 · FY2005 · GM
CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME$58,265
P41 · FY2005 · RR
Survival Mechanisms of Invasive Carcinoma Cells$334,106
R01 · FY2004 · CA
Mechanisms of Lamellipodia Growth &Retraction$328,475
R01 · FY2004 · GM
CELL MIGRATION/SURVIVAL: FOCAL ADHESION TARGETING LASP-1$3,615
P41 · FY2004 · RR
Survival Mechanisms of Invasive Carcinoma Cells$334,106
R01 · FY2003 · CA
Mechanisms of Lamellipodia Growth &Retraction$328,475
R01 · FY2003 · GM
SIGNALING MECHANISMS OF CELL MOTILITY &TUMOR METASTASIS$250,020
R29 · FY2002 · CA
SIGNALING MECHANISMS OF CELL MOTILITY &TUMOR METASTASIS$122,500
R29 · FY2001 · CA
SIGNALING MECHANISMS OF CELL MOTILITY &TUMOR METASTASIS$122,500
R29 · FY2000 · CA